No Data
Maxim Group Maintains Rani Therapeutics(RANI.US) With Buy Rating, Maintains Target Price $15
Express News | Watching Rani Therapeutics; Zacks Small-Cap Research Gives Stock $12 Price Valuation
Oppenheimer Maintains Rani Therapeutics(RANI.US) With Buy Rating, Maintains Target Price $17
Analysts Are Bullish on These Healthcare Stocks: Avadel Pharmaceuticals (AVDL), Rani Therapeutics Holdings (RANI)
Rani Therapeutics Hldgs Analyst Ratings
H.C. Wainwright Maintains Rani Therapeutics(RANI.US) With Buy Rating, Maintains Target Price $9